M 617 (Levetiracetam 750 mg)

This pill with imprint "M 617" is White, Capsule-shape and has been identified as Levetiracetam 750 mg. It is manufactured by Mylan Pharmaceuticals Inc..

Levetiracetam is used in the treatment of seizures; epilepsy; bipolar disorder; new daily persistent headache; neuralgia (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 750 mg is not a controlled substance under the Controlled Substance Act (CSA).

Levetiracetam

Imprint:

M 617

Strength:

750 mg

Color:

White

Size:

19.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Pyrrolidine anticonvulsants

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-5617

Inactive Ingredients:

silicon dioxide
croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
sodium lauryl sulfate
titanium dioxide
triacetin

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
51079-0822	UDL Laboratories Inc

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.